Common name |
B-hCD106 MC38 | Catalog number | 321912 |
Aliases | VCAM1; INCAM-100 | Disease | Colon carcinoma |
Organism |
Mouse |
Strain | C57BL/6 |
Tissue types | Colon | Tissue | Colon |
Subcutaneous homograft tumor growth of B-hCD106 MC38 cells. B-hCD106 MC38 cells (5x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 7-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCD106 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.
B-hCD106 MC38 tumor cells growth of individual mice. B-hCD106 MC38 cells (5x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 7-week-old, n=6). As shown in panel, B-hCD106 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.
Protein expression analysis of tumor cells
B-hCD106 MC38 cells were subcutaneously transplanted into C57BL/6 mice (n=6). At the end of the experiment, tumor cells were harvested and assessed for human CD106 expression by flow cytometry. As shown, human CD106 was highly expressed on the surface of tumor cells. Therefore, B-hCD106 MC38 cells can be used for in vivo efficacy studies of novel CD106 therapeutics.